c-Jun N-Terminal Kinase Promotes Stress Granule Assembly and Neurodegeneration in C9orf72-Mediated ALS and FTD.


Journal

The Journal of neuroscience : the official journal of the Society for Neuroscience
ISSN: 1529-2401
Titre abrégé: J Neurosci
Pays: United States
ID NLM: 8102140

Informations de publication

Date de publication:
26 04 2023
Historique:
received: 20 09 2022
revised: 09 02 2023
accepted: 15 03 2023
medline: 17 5 2023
pubmed: 5 4 2023
entrez: 4 4 2023
Statut: ppublish

Résumé

Stress granules are the RNA/protein condensates assembled in the cells under stress. They play a critical role in the pathogenesis of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). However, how stress granule assembly is regulated and related to ALS/FTD pathomechanism is incompletely understood. Mutation in the C9orf72 gene is the most common cause of familial ALS and FTD. C9orf72 mutation causes the formation of toxic dipeptide repeats. Here we show that the two most toxic dipeptide repeats [i.e., poly(GR) and poly(PR)] activate c-Jun N-terminal kinase (JNK) via the ER-stress response protein IRE1 using fly and cellular models. Further, we show that activated JNK promotes stress granule assembly in cells by promoting the transcription of one of the key stress granule proteins (i.e., G3BP1) by inducing histone 3 phosphorylation. Consistent with these findings, JNK or IRE1 inhibition reduced stress granule formation, histone 3 phosphorylation, G3BP1 mRNA and protein levels, and neurotoxicity in cells overexpressing poly(GR) and poly(PR) or neurons derived from male and female C9ALS/FTD patient-induced pluripotent stem cells. Our findings connect ER stress, JNK activation, and stress granule assembly in a unified pathway contributing to C9ALS/FTD neurodegeneration.

Identifiants

pubmed: 37015810
pii: JNEUROSCI.1799-22.2023
doi: 10.1523/JNEUROSCI.1799-22.2023
pmc: PMC10146492
doi:

Substances chimiques

C9orf72 Protein 0
C9orf72 protein, human 0
Dipeptides 0
DNA Helicases EC 3.6.4.-
G3BP1 protein, human EC 3.6.4.12
Histones 0
JNK Mitogen-Activated Protein Kinases EC 2.7.11.24
Poly-ADP-Ribose Binding Proteins 0
RNA Helicases EC 3.6.4.13
RNA Recognition Motif Proteins 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S. Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3186-3197

Subventions

Organisme : NIH HHS
ID : P40 OD018537
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS117461
Pays : United States

Informations de copyright

Copyright © 2023 the authors.

Auteurs

Talanjeri Gopalakrishna Sahana (TG)

Department of Neuroscience, Mayo Clinic, Jacksonville, Florida 32224 TalanjeriGopalakrishna.Sahana@mayo.edu ke.zhang@szbl.ac.cn.

Katherine Johnson Chase (KJ)

Department of Neuroscience, Mayo Clinic, Jacksonville, Florida 32224.

Feilin Liu (F)

Department of Neuroscience, Mayo Clinic, Jacksonville, Florida 32224.

Thomas E Lloyd (TE)

Department of Neurology, Johns Hopkins School of Medicine, Baltimore, Maryland 21205.

Wilfried Rossoll (W)

Department of Neuroscience, Mayo Clinic, Jacksonville, Florida 32224.
Neuroscience Graduate Program, Mayo Clinic Graduate School of Biomedical Sciences, Jacksonville, Florida 32224.

Ke Zhang (K)

Department of Neuroscience, Mayo Clinic, Jacksonville, Florida 32224 TalanjeriGopalakrishna.Sahana@mayo.edu ke.zhang@szbl.ac.cn.
Neuroscience Graduate Program, Mayo Clinic Graduate School of Biomedical Sciences, Jacksonville, Florida 32224.
Institute of Neurological and Psychiatric Disorders, Shenzhen Bay Laboratory, Gaoke Innovation Centre A16, Guangqiao Rd, Shenzhen, Guangdong 518107, China, P.R.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH